None of us, let me repeat, NONE OF US, have any clue as to what is going on behind the scenes and yet we keep reading how if management doesn't do this, then it means they dropped the ball, blah, blah blah. If you have that little faith in the management of this company (or any company), why would you own a single share other than for day trading purposes? Everyone needs to take a deep breath and relax.
This whole thing unfortunately will still take many, many months to play out and management is doing exactly what it should be doing and making sure they make the most informed decision possible and not make a rash decision. They are the ones who have the contact with the various agencies and governments, they are the ones who know the status of the hold and where they are with the response, they are the ones who know the exact results of the trials and what the elevated cytokine levels means in terms of testing along with many things that I haven't even thought of.
While from the outside we think management should be in the public eye shouting their decision from the rooftops, that would be the wrong move IMO. We have the drug that is the furthest along, period. These vaccines that are getting fast track approval FOR TESTING will take many, many months and probably years to figure out if they work, let alone if they are safe to give to healthy people who MIGHT have exposure that COULD result in getting the disease. Management needs to get the clinical hold cleared and work with the FDA and other agencies to get that done without distractions caused by ramping up at an incorrect dose to "just get it over there".
No matter how good a vaccine works in the clinic in a first world country, it will be entirely different in the jungles of Africa. Same thing with TKM-Ebola once it gets over there, which I have no doubt in my mind it will get over there in very large quantities in a few months. It is the only drug tested for safety in humans coupled with the fact it has proven 100% efficacy in NHP's if given after a deadly exposure of Ebola within 3 days. No other drug or company can say the same thing.
While some want to portray this as an immediate need for management do something, they are right to a point. Management needs to work around the clock to do what is in the best interest of its shareholders which includes working around the clock to assist with this human tragedy. My money is on the side of management who I have faith is doing exactly that.
In the long run, most of us are here for the HBV program and that is what will bring us to the levels we only dream of. I have always felt that the Ebola program would provide a very nice floor in our stock price once it gets through the testing and approval process. And that was before the current outbreak got totally out of control. With the current outbreak once it gets over in large quantities, our stock price will be much higher than it is now but still a fraction of what we will see if/when our HBV results show positive data.
I know that many don't agree with me but I really hope that management doesn't succumb to the pressure of the shareholders to have them "just do something publicly". I want them to continue to make measured decisions and that is what it looks like they are doing to me.